![Shlomo Yanai, Teva's president and chief executive, speaks to the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly Shlomo Yanai, Teva's president and chief executive, speaks to the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly](https://c8.alamy.com/comp/2D1NC3K/shlomo-yanai-tevas-president-and-chief-executive-speaks-to-the-media-during-a-news-conference-in-tel-aviv-july-27-2010-teva-pharmaceutical-industries-the-worlds-largest-generic-drugmaker-reported-higher-quarterly-net-profit-on-tuesday-boosted-by-sales-of-generic-medicines-and-its-own-branded-multiple-sclerosis-treatment-copaxone-reutersnir-elias-israel-tags-business-headshot-2D1NC3K.jpg)
Shlomo Yanai, Teva's president and chief executive, speaks to the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly
![Teva Pharmaceutical (TEVA) presents at Global High Yiled & Leveraged Finance Virtual Conference-slideshow (NYSE:TEVA) | Seeking Alpha Teva Pharmaceutical (TEVA) presents at Global High Yiled & Leveraged Finance Virtual Conference-slideshow (NYSE:TEVA) | Seeking Alpha](https://static1.seekingalpha.com/uploads/sa_presentations/979/66979/slides/1.jpg?1614966828)
Teva Pharmaceutical (TEVA) presents at Global High Yiled & Leveraged Finance Virtual Conference-slideshow (NYSE:TEVA) | Seeking Alpha
Teva to Host Conference Call to Discuss Third Quarter 2022 Financial Results at 8 a.m. ET on November 3, 2022
![Teva to Host Conference Call to Discuss Third Quarter 2022 Financial Results at 8 a.m. ET on November 3, 2022 | Business Wire Teva to Host Conference Call to Discuss Third Quarter 2022 Financial Results at 8 a.m. ET on November 3, 2022 | Business Wire](https://mms.businesswire.com/media/20221006005712/en/739014/23/teva_RGB_JPEG.jpg)
Teva to Host Conference Call to Discuss Third Quarter 2022 Financial Results at 8 a.m. ET on November 3, 2022 | Business Wire
![Shlomo Yanai, Teva's president and chief executive, addresses the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly net Shlomo Yanai, Teva's president and chief executive, addresses the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly net](https://c8.alamy.com/comp/2D1M57M/shlomo-yanai-tevas-president-and-chief-executive-addresses-the-media-during-a-news-conference-in-tel-aviv-july-27-2010-teva-pharmaceutical-industries-the-worlds-largest-generic-drugmaker-reported-higher-quarterly-net-profit-on-tuesday-boosted-by-sales-of-generic-medicines-and-its-own-branded-multiple-sclerosis-treatment-copaxone-reutersnir-elias-israel-tags-business-2D1M57M.jpg)
Shlomo Yanai, Teva's president and chief executive, addresses the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly net
![TEVA PHARMA @ ANZAN Introducing Teva Pharma to the ANZAN conference in Auckland requires a lot of 'presence… | Experiential marketing, Experiential, Branding design TEVA PHARMA @ ANZAN Introducing Teva Pharma to the ANZAN conference in Auckland requires a lot of 'presence… | Experiential marketing, Experiential, Branding design](https://i.pinimg.com/736x/fa/d7/e9/fad7e9d456fb75d4dc1a2540bcb9af95--auckland-exhibition.jpg)
TEVA PHARMA @ ANZAN Introducing Teva Pharma to the ANZAN conference in Auckland requires a lot of 'presence… | Experiential marketing, Experiential, Branding design
![Teva to Settle US Opioid Lawsuits for $4.35 Billion | The Jewish Press - JewishPress.com | David Israel | 28 Tammuz 5782 – July 27, 2022 | JewishPress.com Teva to Settle US Opioid Lawsuits for $4.35 Billion | The Jewish Press - JewishPress.com | David Israel | 28 Tammuz 5782 – July 27, 2022 | JewishPress.com](https://www.jewishpress.com/wp-content/uploads/2022/07/Teva-Pharmaceutical-Industries-CEO-Kare-Schultz-speaks-at-a-press-conference-at-the-Tel-Aviv-Stock-Exchange-February-19-2020..jpg)